Ligand validation:9J3V

ILE: ISOLEUCINE

ILE is a Ligand Of Interest in 9J3V designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
9J3V_ILE_B_303	45%	63%	0.159	0.892	0.75	0.67	-	-	0	0	100%	1
9J3V_ILE_C_303	45%	61%	0.166	0.897	0.81	0.68	-	-	2	0	100%	1
9J3V_ILE_F_303	43%	63%	0.149	0.873	0.77	0.66	-	-	7	0	100%	1
9J3V_ILE_D_303	38%	63%	0.165	0.867	0.82	0.61	-	-	2	0	100%	1
9J3V_ILE_A_303	27%	64%	0.247	0.896	0.84	0.55	-	-	2	0	100%	1
9PRR_ILE_D_301	83%	68%	0.089	0.947	0.73	0.52	-	-	0	0	100%	1
9D2S_ILE_A_601	100%	64%	0.026	0.994	0.63	0.75	-	-	0	0	100%	1
4OAT_ILE_A_501	99%	52%	0.052	0.984	0.82	1.04	-	-	0	0	100%	1
9D2R_ILE_A_601	98%	48%	0.052	0.975	0.76	1.22	-	2	1	0	100%	1
2ZBC_ILE_A_85	97%	35%	0.054	0.966	1.57	1	2	-	0	0	100%	1
5N0L_ILE_C_201	96%	58%	0.067	0.978	0.86	0.77	-	-	1	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.